Stephen Ackland

Professional Summary for Professor Stephen Ackland

Professor Stephen Ackland is a distinguished medical oncologist and academic based at the University of Newcastle, Australia. With a career spanning several decades, he has made significant contributions to cancer research, clinical practice, and medical education, particularly in the field of oncology.

Academic Background and Degrees

Professor Ackland holds advanced qualifications in medicine and oncology. While specific details of his degrees and institutions are not fully detailed in public sources, he is recognized as a qualified medical practitioner with specialist training in medical oncology, consistent with his senior academic and clinical roles.

Research Specializations and Academic Interests

Professor Ackland's research primarily focuses on cancer treatment and clinical trials, with a particular emphasis on gastrointestinal and urological cancers. His work explores novel therapeutic approaches, drug development, and improving patient outcomes through evidence-based practice. He is also deeply involved in translational research, bridging laboratory findings with clinical applications.

Career History and Appointments

• Professor of Medical Oncology at the University of Newcastle, Australia.
• Director of the Department of Medical Oncology at Newcastle Mater Hospital.
• Senior Staff Specialist in Medical Oncology, providing clinical leadership in cancer care.
• Active member of national and international oncology research networks, including collaborative clinical trial groups.

Major Awards, Fellowships, and Honors

While specific awards and honors are not widely documented in public sources, Professor Ackland's leadership roles and contributions to oncology suggest recognition within his field. His sustained involvement in high-impact research and clinical practice reflects a respected standing among peers.

Key Publications

Professor Ackland has authored and co-authored numerous peer-reviewed articles in leading medical and oncology journals. Below is a selection of notable publications based on publicly available data:

• 'Phase II study of axitinib in patients with advanced neuroendocrine tumors' - 2015 (co-author).
• 'Clinical trials in gastrointestinal cancers: The Australian perspective' - various contributions across years (specific dates vary in records).
• Multiple papers on chemotherapy regimens and targeted therapies for urological and gastrointestinal cancers (specific titles and years available in academic databases like PubMed).

His publication record demonstrates a consistent focus on advancing cancer treatment through rigorous clinical research.

Influence and Impact on Academic Field

Professor Ackland has had a profound impact on the field of medical oncology, particularly in Australia. Through his leadership in clinical trials, he has contributed to the development and evaluation of new cancer therapies, directly influencing treatment protocols and patient care standards. His role as an educator at the University of Newcastle has also shaped the next generation of oncologists and researchers, fostering a culture of evidence-based medicine.

Public Lectures, Committee Roles, and Editorial Contributions

• Regular speaker at national and international oncology conferences, sharing insights on cancer treatment advancements.
• Member of key committees within Australian oncology networks, including the Australasian Gastrointestinal Trials Group (AGITG).
• Contributor to editorial boards and peer-review processes for oncology journals (specific roles not fully detailed in public sources).